116 related articles for article (PubMed ID: 38408314)
1. Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy.
Wang MM; Deng DP; Zhou AM; Su Y; Yu ZH; Liu HK; Su Z
Inorg Chem; 2024 Mar; 63(10):4758-4769. PubMed ID: 38408314
[TBL] [Abstract][Full Text] [Related]
2. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
3. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
5. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
6.
Kim S; Sundaram A; Mathew AP; Hareshkumar VS; Mohapatra A; Thomas RG; Bui TTM; Moon K; Kweon S; Park IK; Jeong YY
Biomater Sci; 2023 Sep; 11(18):6177-6192. PubMed ID: 37504889
[TBL] [Abstract][Full Text] [Related]
7. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs.
Kuang Y; Balakrishnan K; Gandhi V; Peng X
J Am Chem Soc; 2011 Dec; 133(48):19278-81. PubMed ID: 22035519
[TBL] [Abstract][Full Text] [Related]
9. Steroidal alkaloid solanidine impedes hypoxia-driven ATM phosphorylation to switch on anti-angiogenesis in lung adenocarcinoma.
Sherapura A; Siddesh BM; Malojirao VH; Thirusangu P; Avin BRV; Kumari NS; Ramachandra YL; Prabhakar BT
Phytomedicine; 2023 Oct; 119():154981. PubMed ID: 37531902
[TBL] [Abstract][Full Text] [Related]
10. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
[TBL] [Abstract][Full Text] [Related]
11. Radio-resistance of hypoxic tumors: exploring the effects of oxygen and x-ray radiation on non-small lung cancer cell lines.
Hanley R; Pagliari F; Garcia-Calderón D; Fernandes Guerreiro J; Genard G; Jansen J; Nisticò C; Marafioti MG; Tirinato L; Seco J
Radiat Oncol; 2023 May; 18(1):81. PubMed ID: 37173741
[TBL] [Abstract][Full Text] [Related]
12. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
[TBL] [Abstract][Full Text] [Related]
13. GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo-Chemodynamic Combination Therapy.
Zhu P; Luo W; Qian J; Meng C; Shan W; Xu Z; Zhang W; Liu X; Ling Y
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641443
[TBL] [Abstract][Full Text] [Related]
14. Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.
Xiao X; Chen M; Zhang Y; Li L; Peng Y; Li J; Zhou W
J Nanobiotechnology; 2022 Sep; 20(1):410. PubMed ID: 36109814
[TBL] [Abstract][Full Text] [Related]
15. Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy.
Zhuang F; Ma Q; Dong C; Xiang H; Shen Y; Sun P; Li C; Chen Y; Lu B; Chen Y; Huang B
ACS Nano; 2022 Apr; 16(4):5439-5453. PubMed ID: 35357810
[TBL] [Abstract][Full Text] [Related]
16. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
[TBL] [Abstract][Full Text] [Related]
17. A Concerted Redox- and Light-Activated Agent for Controlled Multimodal Therapy against Hypoxic Cancer Cells.
Liu J; Prentice AW; Clarkson GJ; Woolley JM; Stavros VG; Paterson MJ; Sadler PJ
Adv Mater; 2023 May; 35(19):e2210363. PubMed ID: 36787500
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
19. O-carboxymethyl chitosan based pH/hypoxia-responsive micelles relieve hypoxia and induce ROS in tumor microenvironment.
Jiang L; Zhang M; Bai Y; Cui F; Zhang C; Wang Z; Si S; Yang L; Wang Y; Zhang Y; Li L; Liu S; Wei X; Wang Y; Xu Y; Meng J
Carbohydr Polym; 2022 Jan; 275():118611. PubMed ID: 34742454
[TBL] [Abstract][Full Text] [Related]
20. Development and biological evaluation of AzoBGNU: A novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity.
Liu Q; Wang X; Li J; Wang J; Sun G; Zhang N; Ren T; Zhao L; Zhong R
Biomed Pharmacother; 2021 Dec; 144():112338. PubMed ID: 34678728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
